Prevention and treatment of cryptosporidiosis in immunocompromised patients: A Cochrane review

Ibrahim I. Abubakar; Sani H. Aliyu; Chitra Arumugam; Paul R. Hunter; Nuhu Usman

doi:10.1002/14651858.CD004932.pub2

Prevention and treatment of cryptosporidiosis in immunocompromised patients: A Cochrane review

Ibrahim I. Abubakar, Sani H. Aliyu, Chitra Arumugam, Paul R. Hunter, Nuhu Usman

Research output: Contribution to journal › Article

162 Citations (Scopus)

Abstract

Cryptosporidiosis is a disease that causes diarrhoea, and can be life‐threatening in individuals whose bodies are not able to resist infections. It causes disease in the both the developed and the developing world. This review of trials found insufficient evidence to say whether any drug is able to reduce or cure the symptoms of Cryptosporidium infection or to effectively kill the organism among individuals who cannot resist infections. A limited amount of evidence was found indicating that the drug nitaxozanide can kill the organism in individuals with a normal immunity.

Original language	English
Article number	CD004932
Journal	Cochrane Database of Systematic Reviews
Volume	1
DOIs	https://doi.org/10.1002/14651858.CD004932.pub2
Publication status	Published - 2007

Access to Document

10.1002/14651858.CD004932.pub2

Cite this

@article{d635731868404122b92bf2f9ad39071e,

title = "Prevention and treatment of cryptosporidiosis in immunocompromised patients: A Cochrane review",

abstract = "Cryptosporidiosis is a disease that causes diarrhoea, and can be life‐threatening in individuals whose bodies are not able to resist infections. It causes disease in the both the developed and the developing world. This review of trials found insufficient evidence to say whether any drug is able to reduce or cure the symptoms of Cryptosporidium infection or to effectively kill the organism among individuals who cannot resist infections. A limited amount of evidence was found indicating that the drug nitaxozanide can kill the organism in individuals with a normal immunity.",

author = "Abubakar, {Ibrahim I.} and Aliyu, {Sani H.} and Chitra Arumugam and Hunter, {Paul R.} and Nuhu Usman",

year = "2007",

doi = "10.1002/14651858.CD004932.pub2",

language = "English",

volume = "1",

journal = "Cochrane Database of Systematic Reviews",

issn = "1361-6137",

publisher = "Wiley",

}

TY - JOUR

T1 - Prevention and treatment of cryptosporidiosis in immunocompromised patients: A Cochrane review

AU - Abubakar, Ibrahim I.

AU - Aliyu, Sani H.

AU - Arumugam, Chitra

AU - Hunter, Paul R.

AU - Usman, Nuhu

PY - 2007

Y1 - 2007

N2 - Cryptosporidiosis is a disease that causes diarrhoea, and can be life‐threatening in individuals whose bodies are not able to resist infections. It causes disease in the both the developed and the developing world. This review of trials found insufficient evidence to say whether any drug is able to reduce or cure the symptoms of Cryptosporidium infection or to effectively kill the organism among individuals who cannot resist infections. A limited amount of evidence was found indicating that the drug nitaxozanide can kill the organism in individuals with a normal immunity.

AB - Cryptosporidiosis is a disease that causes diarrhoea, and can be life‐threatening in individuals whose bodies are not able to resist infections. It causes disease in the both the developed and the developing world. This review of trials found insufficient evidence to say whether any drug is able to reduce or cure the symptoms of Cryptosporidium infection or to effectively kill the organism among individuals who cannot resist infections. A limited amount of evidence was found indicating that the drug nitaxozanide can kill the organism in individuals with a normal immunity.

U2 - 10.1002/14651858.CD004932.pub2

DO - 10.1002/14651858.CD004932.pub2

M3 - Article

VL - 1

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

M1 - CD004932

ER -